Close Menu

NEW YORK (GenomeWeb) – AstraZeneca will use Bina Technologies' genome analysis software as an enterprise platform to support its development work across three therapeutic areas, the companies said today.

Under the collaboration agreement, the pharma company will adopt the Bina Genomic Management Solution (GMS) globally to support genomic data analysis and management as part of its development of drugs in oncology, cardiovascular and metabolic disease, respiratory disease, inflammation, and autoimmunity. AstraZeneca will also become the first member of the Bina Alliance Program.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.